Medicare's outdated reimbursement system is jeopardizing rural office-based medical practices by underpaying for advanced outpatient procedures, leading to consolidation and increased healthcare costs. Proposed reforms aim to preserve independent care and improve access.

CMS expands Medicare drug price controls to 25 medications, achieving $12 billion savings with new Maximum Fair Prices starting 2026 and 2027 for chronic and cancer treatments.

CMS reveals new 2027 price caps for 15 Medicare Part D drugs, projected to save billions federally and reduce patient costs under the Inflation Reduction Act negotiations.

Budget cuts in Washington D.C. are reducing safety net health programs, causing medical insurance loss and worsening health conditions among low-income residents.

Medicare Advantage enrollment surges as hospitals report care delays and increased administrative burdens. Explore the impacts on costs, provider networks, and Medicare policy reforms in 2025.

Senate Republicans oppose Democrats' straight extension of expiring Obamacare subsidies, proposing a two-year plan with income caps and premium adjustments, amid bipartisan negotiation challenges.

Medicare Advantage plans face enrollment decline in 2026 as insurers reduce benefits and brokers lose commissions; CMS proposes star rating changes boosting insurer profits while reversing equity measures.

Uncertainty over Affordable Care Act subsidies risks higher costs for ACA enrollees and employer-based insurance holders, raising market and policy challenges.

The ACO Assignment Improvement Act enhances Medicare's Accountable Care Organizations by including nurse practitioners, physician assistants, and clinical nurse specialists in patient assignment, expanding coordinated care access.

CMS unveils significant Medicare Advantage and Part D changes for 2027, including Star Ratings overhaul and increased quality bonus payments, impacting Medicare spending by $14B.